WINNING STRATEGIES WASHINGTON

Lobbying for KALEO · Pharmaceutical development and manufacturing

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $10,000.00 income · posted Oct 19, 2025

Lobbying activity 5

Health Issues

Legislation related to prescription drug prices, access to epinephrine in schools, childcare, and other community settings

Pharmacy

Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues

Defense

Medical countermeasures research and development

Budget/Appropriations

Medical countermeasures research and development

Aviation/Airlines/Airports

FAA reauthorization provisions related to emergency medicine.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.